FDA.reportPublic FDA data

mark. For Gooness Face

Manufacturer
Avon Products, Inc.
Effective date
2013-03-08
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:34:50

Label at a glance#

Productmark. For Gooness Face Antioxidant Skin Moisturizing
Active ingredientHOMOSALATE, OCTINOXATE, OCTISALATE, OXYBENZONE, AVOBENZONE
Label structure8 sections

Storage and handling

​Other information ​ ​protect the product in this container from excessive heat and direct sun

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

​Active Ingredients

​​Homosalate 8.0%.........

Octinoxate 7.5%...........

Octisalate 5.0%............

Oxybenzone 5.0%..........

Avobenzone 3.0%..........

OTC - PURPOSE SECTION

​ Purpose

​ ​...........Sunscreen

...........Sunscreen

...........Sunscreen

...........Sunscreen

...........Sunscreen

INDICATIONS & USAGE SECTION

​Uses

  • ​​helps prevent sunburn
  • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

WARNINGS SECTION

​Warnings

​For external use only

OTC - DO NOT USE SECTION

​Do not use ​on damaged or broken skin

OTC - WHEN USING SECTION

​When using this product​ keep out of eyes. Rinse with water to remove.

OTC - STOP USE SECTION

​Stop use and ask a doctor if ​rash occurs

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

​Keep out of reach of children. ​If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

​Directions

  • ​​apply liberally 15 minutes before sun exposure
  • children under 6 months of age: ask a doctor
  • reapply at least every 2 hours
  • use a water resistant sunscreen if swimming or sweating
  • ​Sun Protection Measures. ​Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
  • limit time in the sun, especially from 10 a.m.-2 p.m.
  • wear long-sleeved shirts, pants, hats, and sunglasses

STORAGE AND HANDLING SECTION

​Other information

  • ​​protect the product in this container from excessive heat and direct sun

INACTIVE INGREDIENT SECTION

​Inactive Ingredients:​ ​ Water/Eau, Butylene Glycol, Glycerin, PEG-8, Dimethicone, Nylon-12, Citrus Medica Limonum (Lemon) Fruit Extract, Pyrus Malus (Apple) Fruit Extract, Fumaria Officinalis Flower/Leaf/Stem Extract, Epilobium Angustifolium Flower/Leaf/Stem Extract, Vanilla Planifolia Fruit Extract, Theobroma Cacao (Cocoa) Extract, Vaccinium Angustifolium (Blueberry) Fruit Extract, Rubus Idaeus (Raspberry) Fruit Extract, Rubus Fruticosus (Blackberry) Fruit Extract, Vitis Vinifera (Grape) Fruit Extract, Tromethamine, Silica, Trimethylsiloxysilicate, Glyceryl Stearate, Hydrogenated Lecithin, Carbomer, Polyglyceryl-3 Diisostearate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Squalane, Dimethicone/Vinyl Dimethicone Crosspolymer, Caprylic/Capric Triglyceride, Fumaric Acid, Citric Acid, Disodium EDTA, Benzyl Alcohol, Cetyl Alcohol, Polysorbate 60, Methylparaben, Propylparaben

OTC - QUESTIONS SECTION

​Questions or Comments? ​ ​Call toll free ​1-800-meetmark

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image of cartonimage of cartonimage of cartonimage of cartonimage of cartonimage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
10096-0144-22019-11-27C16284748780-19855d018-ee1c-cd31-e053-dbdaa90ab51ac13846a9-3af3-41aa-9185-c5e0bfbc2fe8

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10096-0144-1mark. For Gooness FaceAntioxidant Skin Moisturizing50 mL in 1 JARLOTION501
10096-0144-2mark. For Gooness FaceAntioxidant Skin Moisturizing1 in 1 CARTONLOTION11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10096-0144MARK. FOR GOONESS FACE ANTIOXIDANT SKIN MOISTURIZING (HOMOSALATE, OCTINOXATE, OCTISALATE, OXYBENZONE, AVOBENZONE) LOTION [AVON PRODUCTS, INC.]1Legacy NDC, 2 package rows20130312_c13846a9-3af3-41aa-9185-c5e0bfbc2fe8.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
AVOBENZONEACTIVE INGREDIENTG63QQF2NOX1
HOMOSALATEACTIVE INGREDIENTV06SV4M95S1
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD511
OCTISALATEACTIVE INGREDIENT4X49Y0596W1
OXYBENZONEACTIVE INGREDIENT95OOS7VE0Y1
AVOBENZONEACTIVE MOIETYG63QQF2NOX1
HOMOSALATEACTIVE MOIETYV06SV4M95S1
OCTINOXATEACTIVE MOIETY4Y5P7MUD511
OCTISALATEACTIVE MOIETY4X49Y0596W1
OXYBENZONEACTIVE MOIETY95OOS7VE0Y1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10096-014410096-0144-1, 10096-0144-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
HOMOSALATEV06SV4M95SACTIB
OCTINOXATE4Y5P7MUD51ACTIB
OCTISALATE4X49Y0596WACTIB
OXYBENZONE95OOS7VE0YACTIB
AVOBENZONEG63QQF2NOXACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3bb52643-1d5c-423f-8b4f-b7409f7443b3c13846a9-3af3-41aa-9185-c5e0bfbc2fe82013-03-08WarningsExact identifier
spl id: 3bb52643-1d5c-423f-8b4f-b7409f7443b3
spl set id: c13846a9-3af3-41aa-9185-c5e0bfbc2fe8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.